GSK
GSK plc
Stock
$47.03−0.15 (−0.32%)Close Oct 2, 2026
- Operating cash flow, FY2025
- £7.7B
- YoY, FY2025
- +18.1%
- 5-year CAGR
- −1.7%
- 10-year CAGR
- +11.7%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| FY2025 | £7.7B | +18.1% |
| FY2024 | £6.6B | −3.2% |
| FY2023 | £6.8B | −8.6% |
| FY2022 | £7.4B | −6.9% |
| FY2021 | £8.0B | −5.8% |
| FY2020 | £8.4B | +5.2% |
| FY2019 | £8.0B | −4.8% |
| FY2018 | £8.4B | +21.7% |
| FY2017 | £6.9B | +6.5% |
| FY2016 | £6.5B | +152.9% |
| FY2015 | £2.6B | — |